Max Portfolio Pct.
Check
Valuation
Check
Stock Quality:
Max Portfolio Pct.
Check
Valuation
Check
MBOT Price Action
Last 7 days
9.2%
Last 30 days
17.9%
Last 90 days
-25.8%
Trailing 12 Months
147.5%
MBOT RSI Chart
MBOT Valuation
MBOT Price/Sales (Trailing)
The Good, Bad and Ugly
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
MBOT Fundamentals
MBOT Revenue
MBOT Earnings
MBOT Profitability
MBOT Investor Care
Revenue & Growth
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2016 | 119.3K | 118.5K | 114.2K | 0 |
| 2015 | 1.4M | 994.0K | 555.5K | 116.9K |
| 2014 | 943.5K | 684.8K | 442.0K | 1.0M |
| 2013 | 1.0M | 1.0M | 1.1M | 1.2M |
| 2012 | 1.6M | 1.7M | 1.7M | 1.4M |
| 2011 | 1.4M | 1.4M | 1.4M | 1.2M |
| 2010 | 0 | 1.1M | 1.3M | 1.4M |
| 2009 | 0 | 0 | 0 | 992.9K |
Get all data in R, Python etc through our Historical Stock Data APIs
Microbot Medical Inc. operates as a pre-clinical medical device company in the United Kingdom. It primarily engages in the research, design, and development of next generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company also offers LIBERTY, a robotic system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination. In addition, it provides One & Done Technology, an endovascular robotic system for a range of applications in cardiovascular, peripheral vascular, and neurovascular spaces; and NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. Further, the company offers ViRob, an autonomous crawling micro-robot which can be controlled remotely to navigate and crawl in different natural spaces within the human body, including blood vessels, digestive tract, and respiratory system, as well as artificial spaces, such as shunts, catheters, ports, etc. Additionally, it provides ipCAT, a disposable self-propelled locomotive device that is designed to advance in tubular anatomies. The company also has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is headquartered in Hingham, Massachusetts.
| CEO | Mr. Harel Gadot |
|---|---|
| WEBSITE | https://microbotmedical.com |
| SECTOR | Healthcare |
| INDUSTRY | Medical Instruments & Supplies |
| EMPLOYEES | 18 |
